dc.creatorStarnino, Stefania
dc.creatorGalarza, Patricia G.
dc.creatorCarvallo, Marıa Elena Trigoso
dc.creatorBenzaken, Adele Schwartz
dc.creatorBallesteros, Aurora Maldonado
dc.creatorCruz, Olga Marina Sanabria
dc.creatorHernandez, Alina Llop
dc.creatorCarbajal, José Luis Portilla
dc.creatorBorthagaray, Graciela
dc.creatorPayares, Daisy
dc.creatorDillon, Jo-Anne R
dc.date2021-02-15T20:21:49Z
dc.date2021-02-15T20:21:49Z
dc.date2012-10
dc.date.accessioned2023-08-29T20:09:25Z
dc.date.available2023-08-29T20:09:25Z
dc.identifier2090-7958
dc.identifierhttps://journals.lww.com/stdjournal/Fulltext/2012/10000/Retrospective_Analysis_of_Antimicrobial.14.aspx
dc.identifierhttp://sgc.anlis.gob.ar/handle/123456789/2327
dc.identifier10.1097/OLQ.0b013e3182631c9f
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8520672
dc.descriptionFil: Starnino, Stefania. Vaccine and Infectious Diseases Organization, University of Saskatchewan, Saskatoon, Saskatchewan; Canada.
dc.descriptionFil: Galarza, Patricia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
dc.descriptionFil: Carvallo, María Elena Trigoso. Centro Departamental de Vigilancia, Información y Referencia, La Paz; Bolivia.
dc.descriptionFil: Benzaken, Adele Schwartz. Fundção Alfredo da Matta, Manaus – Amazonas; Brasil.
dc.descriptionFil: Ballesteros, Aurora Maldonado. Instituto de Salud Publica, Santiago; Chile.
dc.descriptionFil: Cruz, Olga Marina Sanabria. Instituto Nacional de Salud, Bogotá; Colombia.
dc.descriptionFil: Hernandez, Alina Llop. Instituto de Medicina Tropical “Pedro Kourí”, Ministerio Salud Publica, Habana; Cuba.
dc.descriptionFil: Carbajal, José Luis Portilla. Instituto Nacional de Salud, Lima; Perú.
dc.descriptionFil: Borthagaray, Graciela. Facultad de Química, Universidad de la Republica, Montevideo; Uruguay.
dc.descriptionFil: Payares, Daisy. Instituto Nacional de Higiene “Rafael Rangel” Caracas; Venezuela.
dc.descriptionFil: Dillon, Jo-Anne R. Vaccine and Infectious Diseases Organization, University of Saskatchewan, Saskatoon, Saskatchewan; Canada.
dc.descriptionThe emergence of resistance and treatment failures to third generation cephalosporins prompted the revitalization of the global Gonococcal Antimicrobial Surveillance Program (GASP) to ensure that information regarding trends of the antimicrobial susceptibility of Neisseria gonorrhoeae isolates is up-to-date. Accordingly, former and potential GASP participants in Latin America and the Caribbean were contacted to reinitiate the GASP network in the region and to undertake a retrospective analysis of the antimicrobial susceptibility of N. gonorrhoeae isolates between 2000 and 2009.
dc.formatpdf
dc.languageen
dc.publisherHindawi
dc.relationSexually transmitted diseases
dc.rightsopen
dc.sourceJournal of Sexually Transmitted Diseases 2012; 39(10):813-21.
dc.subjectNeisseria gonorrhoeae
dc.subjectAmérica Latina
dc.titleRetrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone
dc.typeArtículo


Este ítem pertenece a la siguiente institución